Pfizer/BioNTech seek FDA nod for new COVID boosters for children (Reuters)

Reuters
Pfizer/BioNTech seek FDA nod for new COVID boosters for children – Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administrations authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. …

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter